Table 1 Categories of the knowledge outcomes and study definitions
Knowledge outcomes | National recommendations | Knowledge categories | Category definitions |
|---|---|---|---|
Treatment policy for severe malaria | Artesunate for the following 3 severe malaria populations Children and non-pregnant adults; Pregnant women in 1st trimester Pregnant women in 2nd & 3rd trimester | High | Artesunate response for all 3 severe malaria populations |
Medium | Artesunate response for 2 severe malaria populations | ||
Low | Artesunate response for one or none of the populations | ||
Artesunate dose | 2 Weight categories 3 mg/kg for child < 20 kg, 2.4 mg/kg for patient > 20 kg | High | Correct response for 2 weight categories |
Medium | Correct response for one weight category | ||
Low | No correct response for any of the weight categories | ||
Artesunate dosing interval | 3 dosing intervals 12 h between 1st and 2nd dose 12 h between 2nd and 3rd dose 24 h between 3rd and 4th dose | High | Correct response for all 3 dosing intervals |
Medium | Correct response for 2 dosing intervals | ||
Low | Correct response for one or none of the dosing intervals | ||
Artesunate preparation | Solutions for 2 artesunate preparation steps Bicarbonate for reconstitution Saline or 5% dextrose for dilution | High | Correct response for 2 preparation steps |
Medium | Correct response for one preparation step | ||
Low | No correct response for any of the preparation steps | ||
Preferred route of artesunate administration | Intravenous slow bolus | High | IV slow bolus response |
Low | Any other response |